AJTMH ASTMH Job Mart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am. J. Trop. Med. Hyg., 75(4), 2006, pp. 588-596
Copyright © 2006 by The American Society of Tropical Medicine and Hygiene

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Supplemental Figure and Table
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (6)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by KASEHAGEN, L. J.
Right arrow Articles by ZIMMERMAN, P. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by KASEHAGEN, L. J.
Right arrow Articles by ZIMMERMAN, P. A.
Related Collections
Right arrow Epidemiology
Right arrow Malaria

CHANGING PATTERNS OF PLASMODIUM BLOOD-STAGE INFECTIONS IN THE WOSERA REGION OF PAPUA NEW GUINEA MONITORED BY LIGHT MICROSCOPY AND HIGH THROUGHPUT PCR DIAGNOSIS

LAURIN J. KASEHAGEN, IVO MUELLER, DAVID T. McNAMARA, MOSES J. BOCKARIE, BENSON KINIBORO, LAWRENCE RARE, KERRY LORRY, WILL KASTENS, JOHN C. REEDER, JAMES W. KAZURA, AND PETER A. ZIMMERMAN*
Center for Global Health & Diseases, School of Medicine, Case Western Reserve University, Cleveland, OH; Papua New Guinea Institute of Medical Research, Goroka, Papua New Guinea


ABSTRACT
TOP
 ABSTRACT
INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
In Papua New Guinea (PNG), complex patterns of malaria commonly include single and mixed infections of Plasmodium falciparum, P. vivax, P. malariae, and P. ovale. Here, we assess recent epidemiologic characteristics of Plasmodium blood-stage infections in the Wosera region through four cross-sectional surveys (August 2001 to June 2003). Whereas previous studies performed here have relied on blood smear/light microscopy (LM) for diagnosing Plasmodium species infections, we introduce a newly developed, post-polymerase chain reaction (PCR), semi-quantitative, ligase detection reaction-fluorescent microsphere assay (LDR-FMA). A direct comparison of the two methods for > 1,100 samples showed that diagnosis was concordant for > 80% of the analyses performed for P. falciparum (PF), P. vivax (PV), and P. malariae (PM). Greater sensitivity of the LDR-FMA accounted for 75% of the discordance between diagnoses. Based on LM, the prevalence of blood-stage PF, PV, and PM infections was found to be markedly reduced compared with an early 1990s survey. In addition, there were significant shifts in age distribution of infections, with PV becoming the most common parasite in children < 4 years of age. Consistent with previous studies, prevalence of all Plasmodium species infections increased significantly in samples analyzed by the PCR-based LDR-FMA. This increase was most pronounced for PM, PO, and mixed infections and in adolescent (10–19 years) and adult age groups, suggesting that LM may lead to under-reported prevalence of less common Plasmodium species, infection complexity, and a skewed distribution of infections towards younger age groups. This study shows that the application of LDR-FMA diagnosis in large epidemiologic studies or malaria control interventions is feasible and may contribute novel insights regarding the epidemiology of malaria.


INTRODUCTION
TOP
 ABSTRACT
 INTRODUCTION
MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Malaria is one of the primary reasons for health center use and admission in endemic areas of Papua New Guinea (PNG).1 We and others have conducted a number of epidemiologic surveys within PNG to improve our understanding of the relationships between malaria parasite infection and disease,2–16 anti-malarial drug and vaccine effectiveness,17–19 and human genetic polymorphisms.20–28 These studies have shown that all four Plasmodium species (P. falciparum [PF], P. vivax [PV], P. malariae [PM], and P. ovale [PO]) cause infection in PNG. Although PF is presently the predominant malaria parasite species, PV and PM were observed to be the majority malaria parasite species before the 1980s.6 The observed change in dominance is thought to have coincided with the development of chloroquine resistance by PF.5 PO is observed infrequently in blood smears but is common when diagnosis is performed using more sensitive polymerase chain reaction (PCR)-based techniques.12 Drug-resistant strains of PF are now distributed widely throughout the coastal lowlands and into highland regions in PNG.29–31 Additionally, a number of PNG-based studies provide evidence that mixed Plasmodium species infections are common and exhibit dynamic fluctuation.11–13,32,33

Prevention and control of human Plasmodium infections through new anti-malarial drugs, vaccines, and vector control strategies requires a thorough knowledge of parasite species and strain prevalence, distribution, and transmission. To evaluate initial and sustained impact of control efforts, it will be necessary to perform diagnosis in a timely manner on thousands of individuals at frequent intervals. To accomplish this, diagnostic strategies must be able to differentiate Plasmodium species with accuracy regardless of infection complexity, and with development of specific probes, should be capable of differentiating strains that vary according to drug susceptibility or antigenic variation. It is also important for diagnostic strategies to provide semi-quantitative assessment of Plasmodium species and strain infection levels. Finally, it would be most efficient if the same approaches used to evaluate human infections could also be used to evaluate the vectorial capacity of mosquito populations.

Here, we report on characteristics of Plasmodium blood-stage infections in the Wosera region of PNG using standard blood smear microscopy and molecular epidemiologic tools. Prevalence and parasite levels were evaluated after diagnosis by light microscopy (LM) and a semi-quantitative, Plasmodium species-specific, post-PCR/ligase detection reaction–fluorescent microsphere-based detection assay (LDR-FMA).34 Continuous sample processing from DNA extraction through data analysis in a 96-well plate format avoids cumbersome aspects of previously used molecular diagnostic assays. The performance, versatility, and capacity of this DNA-based assay addresses many challenges confronting diagnosis in large-scale malaria control programs.


MATERIALS AND METHODS
TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
RESULTS
 DISCUSSION
 REFERENCES
 
Study population and blood sample collection. The study was conducted in the Wosera district of East Sepik Province.8 This region of PNG is characterized by perennial transmission of malaria, with an entomologic inoculation rate of ~30 bites/person/yr.35,36 Between August 2001 and June 2003, we conducted a series of four cross-sectional surveys at 6-month intervals within 29 Wosera villages participating in collaborative research studies between Case Western Reserve University and the PNG Institute of Medical Research (PNGIMR). These surveys were performed during periods of the year characterized by different rainfall intensities.8 Based on the annually updated PNGIMR census, the combined population of the villages reached 13,000 at the completion of the surveys. The total number of participants in each survey was as follows: Survey A, N = 4,813 (August–November 2001); Survey B, N = 3,476 (April–June 2002); Survey C, N = 4,124 (August–November 2002); Survey D, N = 3,797 (April–June 2003). Demographic information and finger-prick blood samples were collected from each study volunteer. Blood samples were used to produce thick and thin blood smears, determine hemoglobin concentration, and enable human host and parasite DNA extraction. Informed consent was obtained from all adult participants and from the parents or legal guardians of minors. This project was approved by the PNG Medical Research Advisory Committee, the Institutional Review Board for Human Investigation at University Hospitals of Cleveland, and the International Centers for Tropical Disease Research Network/NIAID/NIH.

Blood smear examination. Thick/thin blood smears were prepared as described previously.8,37 Blood smears were stained with a 4% Giemsa solution and examined under oil immersion (x100). PNGIMR expert microscopists evaluated Plasmodium species–specific parasitemia while counting the number of microscope fields containing 200 leukocytes (population average leukocyte counts = 8,000/µL of blood8); parasite counts x 40 = parasites per microliter of blood.

DNA template preparation. DNA was extracted from whole blood (200 µL) using protocols recommended for the QIAamp 96 DNA Blood Kit (QIAGEN, Valencia, CA).

PCR amplification and Plasmodium species–specific LDR-FMA. All methods for PCR amplification of small sub-unit rRNA target sequences and Plasmodium species–specific detection by LDR-FMA were described in detail by McNamara and others.34 Species-specific fluorescence data were collected using Bio-Rad software, Bio-Plex Manager 3.0 (Bio-Rad Laboratories, Hercules, CA). To differentiate the negative from positive fluorescent signals, we analyzed 353 samples from a random sample of American Red Cross blood donors.38 All donors (18–55 years of age) were self-identified as African American, American Oriental, white American, or Hispanic American and had no history of malaria exposure. Median fluorescent intensity (MFI) LDR-FMA signals from these samples were normally distributed (PF: mean 110.9 ± 31.0 [SD], median 110, 99% quantile 187; PV: mean 86.5 ± 30.5, median 85, 99% quantile 158; PM: mean 94.1 ± 30.8, median 93, 99% quantile 173; PO: mean 84.7 ± 31.6, median 85, 99% quantile 163). Samples with MFIs greater than the 99% quantile values were determined to be positive for infection. Before data analysis of the PNG study volunteers, these species-specific background MFI values (99% quantile values) were subtracted from the LDR-FMA signals.

Statistical analyses and graphing. All statistical analyses were conducted using SAS version 9.2 (SAS Institute, Cary, NC) and graphed using GraphPad PRISM version 4.0 (GraphPad Software, San Diego, CA). Plasmodium species prevalence in parasite assemblages was determined as previously described.12,13


RESULTS
TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
DISCUSSION
 REFERENCES
 
Description of the study population. During the four serial cross-sectional surveys (Table 1Go), we collected a total of 16,209 blood samples from 8,793 villagers (67.6% of the population). With the exception of children < 2 years of age, the demographic profile of survey participants was generally representative of Wosera village populations: 49.4% were men, 2.1% were < 2 years, 7.1% were 2.0–3.9 years, 10.4% were 4.0–6.9 years, 11.2% were 7.0–9.9 years, 24.1% were 10.0–19.9 years, 28.5% were 20.0–39.9 years, and 16.7% were ≥ 40 years of age. The age and sex distribution of participants was comparable among the four surveys. In all surveys, the majority of participants were asymptomatic. Only 2.6% (N = 426) of the survey participants had a parasitemia based on light microscopy (LM) and an axillary temperature of at least 37.5°C indicating clinical malaria.


View this table:
[in this window]
[in a new window]
 
TABLE 1
Distribution of cross-sectional survey participants by age group, sex, and survey
 
Prevalence of single and mixed Plasmodium infections. Blood smear/LM results. Overall, 34.9% of all samples showed evidence of a blood-stage malaria infection by LM. The prevalence of each Plasmodium species was as follows: PF, 22.3%; PV, 10.4%; PM, 4.2%; PO, 0.2%. The majority of the blood-stage infections (94.1%) were composed of a single Plasmodium species, whereas 5.9% of the infections contained mixed Plasmodium species. The prevalence of infections differed significantly between surveys (Table 2Go) and among age groups (Figure 1AGo). Generally, the prevalence of different Plasmodium infections was lower in the second year of study (Surveys C and D). While the prevalence of PF infections did not vary significantly between seasons, PV increased and PM infections decreased in the dry season (Surveys A and C).


View this table:
[in this window]
[in a new window]
 
TABLE 2
Prevalence of malaria infections (light microscopy) by survey, study year, and season
 

Figure 1
View larger version (20K):
[in this window]
[in a new window]
  		    FIGURE 1. Prevalence of Plasmodium species infections in different age groups. (A) 2001–2003 surveys (A–D combined). (B) 1990–1992 surveys.8 Any, infected with any Plasmodium species; PF, P. falciparum; PV, P. vivax; PM, P. malariae; Mixed, concurrent infection with more than one Plasmodium species.

 
Plasmodium infections were most frequent in the 7- to 9-and 4- to 6-year-old children (54.7%, CL: 52.4–57.0 and 51.5%, CL: 49.1–53.9, respectively), followed by adolescents (10–19 years: 42.7%, CL: 41.1–44.2), 2–3 year olds (39.7%, CL: 36.9–42.6), adults (20–39 years: 22.6%, CL: 21.4–23.8), infants (0–1 years: 20.8%, CL: 16.6–25.6), and those ≥ 40 years of age (20.7, CL: 19.1–22.2). PV reached peak prevalence in younger children (4–6 years: 24.2%, CL: 22.1–26.3) than PF (7–9 years: 34.7%, CL: 32.5–36.9) or PM (7–9 years: 7.7%, CL: 6.5–9.0). The age distribution of infections by individual species did not differ significantly between surveys.

Overall, the prevalence rates of Plasmodium infections were significantly lower in these surveys compared with those performed from 1990 to 19928 (Figure 1A versus BGo). Prevalence of PF was reduced from 39.6% to 22.2% (RR: 0.56, CL: 0.54–0.58, P < 0.001); PV from 18.3% to 10.4% (RR: 0.57 CL: 0.53–0.60, P < 0.001), and PM from 13.8% to 4.2% (RR: 0.31 CL: 0.28–0.34 P < 0.001). For PF, the reduced prevalence of infections was significantly greater in children 2–6 years of age (RR range: 0.42–0.49) than in older children (7–9 years) and adolescents (RR range: 0.59–0.61, P < 0.01), suggesting that the highest burden of PF infection has shifted into older age groups. A contrasting pattern was observed for PV, where reduced prevalence was significantly greater for adults (RR range: 0.33–0.36) than children 2–9 years of age (RR range: 0.69–0.75, P < 0.001).

Plasmodium species–specific LDR-FMA results. To evaluate diagnosis by the Plasmodium species–specific LDR-FMA, we selected a set (N = 1,182) of samples from the four serial cross-sectional surveys that were representative of the age, sex, and village composition of the Wosera. All samples included in this analysis had a corresponding blood smear evaluated by LM. By this assay, 55.7% of all samples showed evidence of a blood-stage malaria infection. In comparison with LM diagnosis, the prevalence of infection observed by LDR-FMA increased by 1.6-fold for PF (20.6% versus 32.9%, P < 0.001), 2.1-fold for PV (12.7% versus 27.1%, P < 0.001), 3.1-fold for PM (4.0% versus 12.4%, P < 0.001), and 22-fold for PO (0.25% versus 5.5%, P < 0.001), with the prevalence of mixed infections increasing from 2.4% to 16.8% (P < 0.001). Mixed species infections were thus present in 30.3% of all LDR-FMA–positive infections compared with only 6.8% of all LM-positive cases.

For all Plasmodium species, the increase in prevalence of infections by the LDR-FMA assay was proportionally larger in the adults and adolescents than in children (Figure 2Go). Consistent with this observation, the prevalence of infection peaked at a later age for LDR-FMA–detectable infections than when diagnosis was performed by LM (Figure 2Go). In all species except PV, where infections were most commonly found in children 7–9 years of age (42.6%), prevalence of infections peaked in older age groups (10–19 years: overall, 69.9%; PF, 48.6%; PM, 20.9%; PO, 9.3%; mixed infections, 25.7%).


Figure 2
View larger version (26K):
[in this window]
[in a new window]
  		    FIGURE 2. Age-specific prevalence of malaria infection as detected by LM and LDR-FMA assay. Solid line, LM; dashed line, LDR-FMA assay; Any, infected with any Plasmodium species; Mixed, concurrent infection with more than one Plasmodium species.

 
Parasite assemblage comparison. To determine whether there was a random distribution of Plasmodium species in the survey population, we analyzed parasite assemblages using the multiple-kind lottery model described previously.12,13 Analyses were performed on both blood smear and LDR-FMA data. Results of the LM analysis of the overall study population in Table 3Go showed that single species infections were observed at higher frequencies than expected, and different mixed Plasmodium species infections were observed at frequencies that were equal to or lower than the expected frequencies. Overall, mixed infections were found in only 2.1% of all samples compared with the expected 3.6% (P < 0.001). In the LDR-FMA diagnostic data, a different pattern was found. Single species and double infections were observed at frequencies equal to or less than expected, whereas triple and quadruple infections assemblages (4.4% versus 1.8%, P < 0.001) and negative samples (44.3% versus 40.5%, P = 0.008) were more significantly common than expected. Mixed infections were most commonly found in older children (4–9 years) and adolescents, with 36.3% to 39.3% of all LDR-FMA–positive infections containing more than one species.


View this table:
[in this window]
[in a new window]
 
TABLE 3
Plasmodium species assemblages by different diagnostic techniques
 
Concordance between LM and LDR-FMA diagnosis. The above results indicate that diagnosis by LDR-FMA detected a higher prevalence of infection than LM. We therefore compared semi-quantitative outcomes in those 1,182 samples that were evaluated with both diagnostic methods (Figure 3A–CGo). In diagnosis of PF, 942 analyses were concordant (79.7%) between the two diagnostic techniques. Among the 240 (20.3%) discordant analyses, 193 samples were LDR-FMA positive and LM negative (LDR-FMA+:LM–), and 47 were LDR-FMA negative and LM positive (LDR-FMA–:LM+; LDR-FMA sensitivity = 0.81 and specificity = 0.79; Figure 3AGo). Where PF diagnosis was LDR-FMA+:LM–, 48 samples were judged by LM as infected with at least one other Plasmodium species. For PF LDR-FMA–:LM+ discordance, 21 samples were identified by LDR-FMA as infected with at least one other Plasmodium species. Diagnosis of PV found that 936 analyses were concordant (79.2%), whereas 246 were discordant. Among the discordant analyses, 208 samples were LDR-FMA+:LM–, and 38 were LDR-FMA–:LM+ (LDR-FMA sensitivity = 0.75 and specificity = 0.80; Figure 3BGo). Where PV diagnosis was LDR-FMA+:LM–, 69 samples were judged by microscopy as infected with at least one other Plasmodium species. For PV LDR-FMA–:LM+ discordance, 13 samples were identified by LDR-FMA as infected with at least one other Plasmodium species. Diagnosis of PM found that 1,053 analyses were concordant (89.1%), and 129 were discordant. Among discordant analyses, 114 samples were LDR-FMA+:LM– and 15 samples were LDR-FMA–:LM+ (LDR-FMA sensitivity = 0.68 and specificity = 0.90; Figure 3CGo). Where PM diagnosis was LDR-FMA+:LM–, 45 samples were judged by LM as infected with at least one other Plasmodium species. For PM LDR-FMA–:LM+ discordance, 11 samples were identified by LDR-FMA as infected with at least one other Plasmodium species.


Figure 3
View larger version (13K):
[in this window]
[in a new window]
  		    FIGURE 3. Association between semi-quantitative blood-stage parasitemia and LDR-FMA fluorescent signal intensity. The association between species-specific Plasmodium fluorescent signal intensity and parasitemia was determined using blood smear LM for N = 1,182 paired samples. Quadrants delineated by the horizontal and vertical bars denote the limits of negative and positive values. Top left quadrant, LDR-FMA+:LM–; top right quadrant, LDR-FMA+:LM+; bottom left quadrant, LDR-FMA–:LM–; bottom right quadrant, LDR-FMA–:LM+. In the top left quadrant, LDR-FMA+:LM– samples designated as + showed evidence of one or more Plasmodium species in the blood smear other than the species detected by LDR-FMA; samples designated as - showed evidence of no other Plasmodium species. In the bottom right quadrant, LDR-FMA–:LM+ positive samples designated as + showed evidence of one or more Plasmodium species by LDR-FMA other than the species detected by microscopy; samples designated as - showed evidence of no other Plasmodium species. Panel A reports results for PF, panel B for PV, and panel C for PM.

 
The overall concordance between microscopy and LDR-FMA for the detection of all possible Plasmodium assemblage combinations was Kw = 0.48 (95% CL: 0.43, 0.53). Based on the weighted {kappa} test,37 56.7% of the samples were 100% concordant, 88.2% of the samples were at least 75% concordant, and 97.6% of the samples were at least 50% concordant (Supplemental Table 1Go).

Correlation between LM parasitemia and LDR-FMA MFI. In contrast to our previous studies where semi-quantitative data on blood-stage Plasmodium species infections was limited to LM, development of the LDR-FMA allowed semi-quantitative assessment of differences in species-specific, blood-stage infection levels by a molecular diagnostic assay.34 In this study, we found positive correlations between the LDR-FMA MFI and LM parasitemia for each of the Plasmodium species parasite infections (N = 1,182 paired samples; PF Pearson’s r = 0.65, 95% CI: 0.62–0.68, P < 0.0001, Figure 3AGo; PV Pearson’s r = 0.55, 95% CI: 0.51–0.59, P < 0.0001, Figure 3BGo; PM Pearson’s r = 0.47, 95% CI: 0.42–0.51, P < 0.0001, Figure 3CGo).

Correlation between LM parasitemia/LDR-FMA MFI and age. For samples where diagnosis was performed by both assays, we compared these semi-quantitative results for both techniques to the age of the study participants. As in earlier studies,8,13 parasitemia assessed by LM decreased significantly with age (PF Pearson’s r = –5% CI: –0.34, –0.15, P < 0.0001, N = 389, Figure 4AGo; PV Pearson’s r = –0.26, 95% CI: –0.36, –0.16, P < 0.0001, N = 320, Figure 4BGo; PM Pearson’s r = –0.25, 95% CI: –0.39, –0.09, P = 0.0028, N = 146, Figure 4CGo). A parallel decrease with age was observed in the LDR-FMA data (PF Pearson’s r = –0.30, 95% CI: –0.39, –0.20, P < 0.0001, N = 389, Figure 4AGo; PV Pearson’s r = –5% CI: –0.36, –0.16, P < 0.0001, N = 320, Figure 4BGo; PM Pearson’s r = –0.19, 95% CI: –0.34, –0.02, P = 0.0224, N = 146, Figure 4CGo).


Figure 4
View larger version (24K):
[in this window]
[in a new window]
  		    FIGURE 4. Age distribution of geometric mean blood-stage parasitemia determined by semi-quantitative blood smear microscopy and LDR-FMA. Blood smear parasitemia (infected red blood cells [IRBCs]/µL of blood) and median fluorescent signal intensity (MFI) for individuals who were positive for Plasmodium species infection by either LDR-FMA and/or LM. (A) P. falciparum. (B) P. vivax. (C) P. malariae. Black circles, LDR-FMA MFI values; gray circles, no. of IRBCs/µL; black solid line, geom. mean LDR-FMA MFI; gray dashed line, geom. mean parasitaemia/µL. Mean values estimated using a symmetric local regression (Loess) smoother with 1 degree of freedom.

 

DISCUSSION
TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
REFERENCES
 
LM, the mainstay of malaria diagnosis in epidemiologic studies, has bedeviled malariologists attempting to assess Plasmodium species infection prevalence in endemic communities for > 100 years.39,40 Recent studies provide a consistent reminder that LM exhibits limited sensitivity for detecting low level infections41–45 and is known to under-estimate significantly the frequency of mixed Plasmodium species infections.12,13,46 To address these shortcomings, a number of nucleic acid–based diagnostic assays have been developed recently that attempt to address the major challenges of diagnosing all four species of human malaria parasites in large epidemiologic studies.47–53 In previous studies, we characterized the prevalence and complexity of mixed Plasmodium species infections using both LM and more sensitive and specific PCR-based techniques in cross-sectional surveys from several different malaria-endemic regions in northern PNG.12,13,37 As in studies outside PNG, the prevalence of Plasmodium blood-stage infections of all types was found to be under-represented by LM compared with observations made by PCR-based methods.48–50,52,54–57 Here we expanded the scope of our surveys in the Wosera to include all 29 villages participating in PNGIMR malaria epidemiology studies. The four surveys summarized here were conducted at 6-month intervals over a 2-year period to monitor general seasonal or annual differences in the prevalence of Plasmodium species infections. More importantly, we took significant steps toward performing efficient large-scale molecular epidemiologic analysis of malaria infection in endemic communities.

Because PCR-based diagnosis of Plasmodium species provides a powerful approach for both species and strain assessment, we continued to refine methods for performing large-scale epidemiologic studies.12,13,34,37 Approaches used here have improved efficiency of sample processing by using 96-well plate–based methods from DNA extraction through data processing and enhanced diagnosis by adding semi-quantitative assessment capabilities comparable to real-time PCR-based methods.34 Details of the Plasmodium species LDR-FMA method were presented recently.34 Results showed that the LDR-FMA was consistently more sensitive than microscopy in detecting Plasmodium infected erythrocytes; numerous mixing experiments showed that the sequence specificity of the LDR-FMA probes constrains the possibility for false-positive diagnoses (only 1/33 of nucleotides was positionally identical among PF, PV, PM, and PO LDR probes).34,37 These assay performance characteristics must be considered in interpreting head-to-head comparisons between the LDR-FMA and LM data from the field-based samples evaluated here.

Data presented in Figure 3A–CGo showed that results for PF, PV, and PM were 80–90% concordant between the two diagnostic methods. Evaluation of the discrepancies between the diagnostic methods showed that LDR-FMA+:LM– outcomes accounted for 80–88% of the observed discordance and is most likely explained by greater sensitivity of the PCR-based assay. LDR-FMA–:LM+ outcomes accounting for 11–20% may have resulted from misdiagnosis, inhibition of PCR amplification of template DNA, or target (ssu rRNA) sequence variability.48,58

With enhanced capabilities of molecular diagnostic methods to perform semi-quantitative analysis of Plasmodium species infections, we anticipate that new elements of discordance will be observed, particularly in field studies performed in regions with complex malaria epidemiology. For example, whereas the correlation between LDR-FMA signal strength and the blood smear parasitemia improved with increasing numbers of infected erythrocytes identified by LM (common in concordance studies between microscopists43,59), we observed a wide range of LDR-FMA fluorescence for samples judged to contain a low number of infected erythrocytes by microscopy. Our results also showed that the range of fluorescent signals varied across 4 logs of fluorescent signal intensity for samples judged by microscopy to be negative. Numerous factors may have contributed to this wide range of LDR-FMA fluorescence associated with low-level parasitemia or for samples deemed negative by microscopy. Although inconsistent estimates have been reported, DNA persisting in circulating blood after parasites have been killed (24–144 hours)60,61 could contribute to high LDR-FMA signal strength in samples with low blood smear parasitemia. Additionally, if the number of PCR amplification cycles was too high, LDR-FMA signals could reach maximum strength for all dilution controls. However, LDR-FMA signal intensities correlating with species-specific controls throughout our studies34 would counter this possibility. Alternatively, because mixed Plasmodium species infections are common in PNG, it is possible that infection complexity may have influenced the accuracy of both species identification and species-specific enumeration of infected erythrocytes. This latter possibility consistently challenges comparisons between LM and molecular diagnostic tools.42,43

Overall comparisons between our study and previous malariometric surveys in the Wosera are limited to blood smear microscopy results because earlier studies did not include molecular diagnostic analyses. Comparing results from our study to the early 1990s surveys of Genton and others8 in 10 Wosera villages uncovers a significant reduction in the prevalence of Plasmodium species infections from 38% to 22.3% for PF, 19.7% to 10.4% for PV, and 15.7% to 4.2% for PM.8 It is potentially important to note that the prevalence of PM has been on a consistent decline since the mid-1980s.2–4,6,8 Explanations underlying this decrease in PM prevalence, beyond apparent susceptibility to malaria control measures, could include morphologic variations that may contribute to misdiagnosis.63 These changes in Plasmodium species prevalence in the Wosera have occurred in the absence of any sustained community-wide malaria control program between 1990 and 2003. During this time, however, the PNG Ministry of Health did change its anti-malarial treatment guidelines from chloroquine or amodiaquine monotherapy to a combination of sulphadoxine-pyrimethamine plus chloroquine or amodiaquine in 2000. Introducing this combination treatment has greatly improved the effectiveness of treatment of PF infections in the study area (Mueller and others, unpublished data). Although no coverage data are available, a gradual increase in the use of insecticide treated nets has also been observed over this region of PNG in recent years.

Despite the important reduction in prevalence of Plasmodium species infections, many features of malaria infection within the Wosera were similar between the early 1990s8 and 2001–2003 surveys reported here. PF and PV remain the predominant malaria species in this endemic community, although their relative importance in different age groups has changed. Detailed observations showed that PV was more prevalent than PF in children < 4 years of age. After 7 years of age, the prevalence of PV declined, and a shift to PF predominance was observed. The earlier age of peak prevalence of PV in both earlier8 and these later surveys suggests that immunity to PV is likely to be acquired at an earlier age than for PF. Although greatly reduced in prevalence, age distribution of PM remains notably similar to that observed by Genton and others.8 These changing patterns between prevalence of parasitemia and age seem to be unique for each species.

While LDR-FMA was only performed on a subset of the total 16,209 samples collected, our results show promise for providing significant new insights into the epidemiology of all four human Plasmodium parasite species. In particular, we show that PV, PM, and PO contribute to a greater burden of infection than appreciated by LM. Sub-patent infections of all species are most commonly found in adolescents and adults. The resulting shift in the age of peak prevalence and complexity of infection suggests that older age groups that have developed clinical immunity may contribute significantly more to the total parasite pool and transmission levels than previously thought. If these low-level infections are treated with indiscriminate use of anti-malarial drugs, this portion of the parasite population may encounter selection pressure favoring acquisition of anti-malarial drug resistance polymorphisms.

Finally, as in earlier studies conducted in PNG12,13 and elsewhere,46,63 mixed Plasmodium species infections were observed more frequently by PCR-based assays compared with LM diagnostic methods. While the apparent shortage of mixed infections by LM might suggest the possibility of cross-species protection from infection, this interpretation is not supported by the LDR-FMA data. Observed patterns in both LM and LDR-FMA studies may be influenced by small-scale (village-to-village) heterogeneity in transmission found in our study population.64,65 The substantial difference in mixed species patterns observed by LM and LDR-FMA reinforces the importance of using a reliable PCR-based diagnostic assay in all studies on mixed Plasmodium species interactions.

Future analyses using LDR-FMA in comparison to blood smear microscopy will evaluate the distribution heterogeneity of Plasmodium species infections within endemic communities, Plasmodium strain (drug resistant and antigenic variants) prevalence and diversity, susceptibility to recurrence of Plasmodium species blood stage infections, and host genetic polymorphism associations with levels of infection and clinical malaria.

Received October 18, 2005. Accepted for publication May 31, 2006.

Acknowledgments: The authors thank W. E. Collins, C. L. King, C. H. King, R. K. Mehlotra, and E. L. Goldman for critical evaluation of this manuscript and B. Genton for allowing reference to original data. This study could not have been conducted without the participation of the Wosera residents and PNGIMR demography, field, data management, and microscopy units.

Financial support: This work was supported by NIAID/NIH Grants AI063135, AI46919, and AI52312.

* Address correspondence to Peter A. Zimmerman, Center for Global Health and Diseases, School of Medicine, Case Western Reserve University, Wolstein Research Building, 4th Floor, 2103 Cornell Road, Cleveland, OH 44106-7286. E-mail: paz{at}case.edu Back

Note: Supplemental Table 1 and supplemental Figure 1 appear online at www.ajtmh.org.

Authors’ addresses: L. J. Kasehagen, Oregon Department of Human Services, Office of Family Health, Portland, OR 97232. D. T. Mc-Namara, W. T. Kastens, J. W. Kazura, and P. A. Zimmerman, Center for Global Health and Diseases, School of Medicine, Case Western Reserve University, Wolstein Research Building, 4th Floor, 2103 Cornell Road, Cleveland, OH 44106-7286. I. Mueller, M. J. Bockarie, B. Kiniboro, L. Rare and K. Lorry, Papua New Guinea Institute of Medical Research, PO Box 60, Goroka, EHP 441, Papua New Guinea. J. C. Reeder, Burnet Institute for Medical Research and Public Health, PO Box 2284, Melbourne, VIC2001, Australia.

Reprint requests: P. A. Zimmerman, Center for Global Health and Diseases, School of Medicine, Case Western Reserve University, Wolstein Research Building 4-125, 2103 Cornell Road, Cleveland, OH 44106-7286, Telephone: 216-368-0508; Fax: 216-368-4825; E-mail: paz{at}case.edu.


REFERENCES
TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 

  1. 2000. Papua New Guinea National Health Plan 2001–2010. Port Moresby: Papua New Guinea Ministry of Health.
  2. Peters W, 1960. Studies on the epidemiology of malaria in New Guinea. 1. Holoendemic malaria—a clinical picture. Trans R Soc Trop Med Hyg 54: 242–249.[Medline]
  3. Peters W, Standfast HA, 1960. Studies on the epidemiology of malaria in New Guinea. 2. Holoendemic malaria—the entomological picture. Trans R Soc Trop Med Hyg 54: 249–254.[Medline]
  4. Desowitz RS, Saave JJ, 1965. The application of the haemagglutination test to a study of the immunity to malaria in protected and unprotected groups in Australian New Guinea. Bull WHO 32: 149–159.[ISI][Medline]
  5. Cattani JA, Tulloch JL, Vrbova H, Jolley D, Gibson FD, Moir JS, Heywood PF, Alpers MP, Stevenson A, Clancy R, 1986. The epidemiology of malaria in a population surrounding Madang, Papua New Guinea. Am J Trop Med Hyg 35: 3–15.[Abstract/Free Full Text]
  6. Desowitz RS, Spark RA, 1987. Malaria in the Maprik area of the Sepik region, Papua New Guinea: 1957–1984. Trans R Soc Trop Med Hyg 81: 175–176.[ISI][Medline]
  7. Cox MJ, Kum DE, Tavul L, Narara A, Raiko A, Baisor M, Alpers MP, Medley GF, Day KP, 1994. Dynamics of malaria parasitaemia associated with febrile illness in children from a rural area of Madang, Papua New Guinea. Trans R Soc Trop Med Hyg 88: 191–197.[ISI][Medline]
  8. Genton B, al-Yaman F, Beck HP, Hii J, Mellor S, Narara A, Gibson N, Smith T, Alpers MP, 1995. The epidemiology of malaria in the Wosera area, East Sepik Province, Papua New Guinea, in preparation for vaccine trials. I. Malariometric indices and immunity. Ann Trop Med Parasitol 89: 359–376.[ISI][Medline]
  9. Genton B, al-Yaman F, Beck HP, Hii J, Mellor S, Rare L, Ginny M, Smith T, Alpers MP, 1995. The epidemiology of malaria in the Wosera area, East Sepik Province, Papua New Guinea, in preparation for vaccine trials. II. Mortality and morbidity. Ann Trop Med Parasitol 89: 377–390.[ISI][Medline]
  10. Shankar AH, Genton B, Semba RD, Baisor M, Paino J, Tamja S, Adiguma T, Wu L, Rare L, Tielsch JM, Alpers MP, West KP Jr, 1999. Effect of vitamin A supplementation on morbidity due to Plasmodium falciparum in young children in Papua New Guinea: A randomised trial. Lancet 354: 203–209.[ISI][Medline]
  11. Bruce MC, Donnelly CA, Alpers MP, Galinski MR, Barnwell JW, Walliker D, Day KP, 2000. Cross-species interactions between malaria parasites in humans. Science 287: 845–848.[Abstract/Free Full Text]
  12. Mehlotra RK, Lorry K, Kastens W, Miller SM, Alpers MP, Bockarie M, Kazura JW, Zimmerman PA, 2000. Random distribution of mixed species malaria infections in Papua New Guinea. Am J Trop Med Hyg 62: 225–231.[Abstract]
  13. Mehlotra RK, Kasehagen LJ, Baisor M, Lorry K, Kazura JW, Bockarie MJ, Zimmerman PA, 2002. Malaria infections are randomly distributed in diverse holoendemic areas of Papua New Guinea. Am J Trop Med Hyg 67: 555–562.[Abstract]
  14. Mueller I, Bjorge S, Poigeno G, Kundi J, Tandrapah T, Riley ID, Reeder JC, 2003. The epidemiology of malaria in the Papua New Guinea highlands: 2. Eastern Highlands Province. P N G Med J 46: 166–179.[Medline]
  15. Mueller I, Taime J, Ivivi R, Yala S, Bjorge S, Riley ID, Reeder JC, 2003. The epidemiology of malaria in the Papua New Guinea highlands: 1. Western Highlands Province. P N G Med J 46: 16–31.[Medline]
  16. Mueller I, Namuigi P, Kundi J, Ivivi R, Tandrapah T, Bjorge S, Reeder JC, 2005. Epidemic malaria in the highlands of Papua New Guinea. Am J Trop Med Hyg 72: 554–560.[Abstract/Free Full Text]
  17. Brabin BJ, Ginny M, Alpers M, Brabin L, Eggelte T, Van der Kaay HJ, 1990. Failure of chloroquine prophylaxis for falciparum malaria in pregnant women in Madang, Papua New Guinea. Ann Trop Med Parasitol 84: 1–9.[ISI][Medline]
  18. al-Yaman F, Genton B, Mokela D, Narara A, Raiko A, Alpers MP, 1996. Resistance of Plasmodium falciparum malaria to amodiaquine, chloroquine and quinine in the Madang Province of Papua New Guinea. P N G Med J 39: 16–22.[Medline]
  19. Genton B, Anders RF, Alpers MP, Reeder JC, 2003. The malaria vaccine development program in Papua New Guinea. Trends Parasitol 19: 264–270.[ISI][Medline]
  20. Booth PB, Tills D, Warlow A, Kopec AC, Mourant AE, Teesdale P, Hornabrook RW, 1982. Red cell antigen, serum protein and red cell enzyme polymorphisms in Karkar Islanders and inhabitants of the adjacent North Coast of New Guinea. Hum Hered 32: 385–403.[ISI][Medline]
  21. Mourant AE, Tills D, Kopec AC, Warlow A, Teesdale P, Booth PB, Hornabrook RW, 1982. Red cell antigen, serum protein and red cell enzyme polymorphisms in Eastern Highlanders of New Guinea. Hum Hered 32: 374–384.[Medline]
  22. Brabin L, Brabin BJ, 1990. Malaria and glucose 6-phosphate de-hydrogenase deficiency in populations with high and low spleen rates in Madang, Papua New Guinea. Hum Hered 40: 15–21.[ISI][Medline]
  23. Genton B, al-Yaman F, Mgone CS, Alexander N, Paniu MM, Alpers MP, Mokela D, 1995. Ovalocytosis and cerebral malaria. Nature 378: 564–565.[Medline]
  24. Allen SJ, O’Donnell A, Alexander ND, Mgone CS, Peto TE, Clegg JB, Alpers MP, Weatherall DJ, 1999. Prevention of cerebral malaria in children in Papua New Guinea by southeast Asian ovalocytosis band 3. Am J Trop Med Hyg 60: 1056–1060.[Abstract]
  25. Zimmerman PA, Woolley I, Masinde GL, Miller SM, McNamara DT, Hazlett F, Mgone CS, Alpers MP, Genton B, Boatin BA, Kazura JW, 1999. Emergence of Fy*A(null) in a Plasmodium vivax-endemic region of Papua New Guinea. Proc Natl Acad Sci USA 96: 13973–13977.[Abstract/Free Full Text]
  26. Patel SS, Mehlotra RK, Kastens W, Mgone CS, Kazura JW, Zimmerman PA, 2001. The association of the glycophorin C exon 3 deletion with ovalocytosis and malaria susceptibility in the Wosera, Papua New Guinea. Blood 98: 3489–3491.[Abstract/Free Full Text]
  27. Maier AG, Duraisingh MT, Reeder JC, Patel SS, Kazura JW, Zimmerman PA, Cowman AF, 2003. Plasmodium falciparum erythrocyte invasion through glycophorin C and selection for Gerbich negativity in human populations. Nat Med 9: 87–92.[ISI][Medline]
  28. Patel SS, King CL, Mgone CS, Kazura JW, Zimmerman PA, 2004. Glycophorin C (Gerbich antigen blood group) and band 3 polymorphisms in two malaria holoendemic regions of Papua New Guinea. Am J Hematol 75: 1–5.[ISI][Medline]
  29. al-Yaman F, Genton B, Mokela D, Narara A, Raiko A, Alpers MP, 1996. Resistance of Plasmodium falciparum malaria to amodiaquine, chloroquine and quinine in the Madang Province of Papua New Guinea, 1990–1993. P N G Med J 39: 16–22.[Medline]
  30. Muller I, Bockarie M, Alpers M, Smith T, 2003. The epidemiology of malaria in Papua New Guinea. Trends Parasitol 19: 253–259.[ISI][Medline]
  31. Mehlotra RK, Mattera G, Bhatia K, Reeder JC, Stoneking M, Zimmerman PA, 2005. Insight into the early spread of chloroquine-resistant Plasmodium falciparum infections in Papua New Guinea. J Infect Dis 192: 2174–2179.[ISI][Medline]
  32. Bruce MC, Galinski MR, Barnwell JW, Donnelly CA, Walmsley M, Alpers MP, Walliker D, Day KP, 2000. Genetic diversity and dynamics of plasmodium falciparum and P. vivax populations in multiply infected children with asymptomatic malaria infections in Papua New Guinea. Parasitology 121: 257–272.
  33. Mueller I, Taime J, Ibam E, Kundi J, Lagog M, Bockarie M, Reeder JC, 2002. Complex patterns of malaria epidemiology in the highlands region of Papua New Guinea. P N G Med J 45: 200–205.[Medline]
  34. McNamara DT, Kasehagen LJ, Grimberg BT, Cole-Tobian J, Collins WE, Zimmerman PA, 2006. Diagnosing infection levels of four human malaria parasite species by a polymerase chain reaction/ligase detection reaction fluorescent microsphere-based assay. Am J Trop Med Hyg 74: 413–421.[Abstract/Free Full Text]
  35. Hii JL, Smith T, Mai A, Mellor S, Lewis D, Alexander N, Alpers MP, 1997. Spatial and temporal variation in abundance of Anopheles (Diptera:Culicidae) in a malaria endemic area in Papua New Guinea. J Med Entomol 34: 193–205.[ISI][Medline]
  36. Hii JL, Smith T, Mai A, Ibam E, Alpers MP, 2000. Comparison between anopheline mosquitoes (Diptera: Culicidae) caught using different methods in a malaria endemic area of Papua New Guinea. Bull Entomol Res 90: 211–219.[ISI][Medline]
  37. McNamara DT, Thomson JM, Kasehagen LJ, Zimmerman PA, 2004. Development of a multiplex PCR-ligase detection reaction assay for diagnosis of infection by the four parasite species causing malaria in humans. J Clin Microbiol 42: 2403–2410.[Abstract/Free Full Text]
  38. Zimmerman PA, Buckler-White A, Alkhatib G, Spalding T, Kubofcik J, Combadiere C, Weissman D, Cohen O, Rubbert A, Lam G, Vaccarezza M, Kennedy PE, Kumaraswami V, Giorgi JV, Detels R, Hunter J, Chopek M, Berger EA, Fauci AS, Nutman TB, Murphy PM, 1997. Inherited resistance to HIV-1 conferred by an inactivating mutation in CC Chemokine Receptor 5: Studies in populations with contrasting clinical phenotypes, defined racial background, and quantified risk. Mol Med 3: 23–36.[Medline]
  39. Ross R, 1910. The measurement of malaria (section 31). Ross R, ed. The Prevention of Malaria. New York: E.P. Dutton & Company, 217–246.
  40. Knowles R, White RS, 1930. Studies in the parasitology of malaria. Indian Medical Research Memoirs 18: 436.
  41. 2000. WHO/MAL/2000.1091 New Perspectives in Malaria Diagnosis. Geneva: World Health Organization.
  42. Ohrt C, Purnomo, Sutamihardja MA, Tang D, Kain KC, 2002. Impact of microscopy error on estimates of protective efficacy in malaria-prevention trials. J Infect Dis 186: 540–546.[ISI][Medline]
  43. McKenzie FE, Sirichaisinthop J, Miller RS, Gasser RA Jr, Wongsrichanalai C, 2003. Dependence of malaria detection and species diagnosis by microscopy on parasite density. Am J Trop Med Hyg 69: 372–376.[Abstract/Free Full Text]
  44. O’Meara WP, McKenzie FE, Magill AJ, Forney JR, Permpanich B, Lucas C, Gasser RA Jr, Wongsrichanalai C, 2005. Sources of variability in determining malaria parasite density by microscopy. Am J Trop Med Hyg 73: 593–598.[Abstract/Free Full Text]
  45. Prudhomme O’meara W, Remich S, Ogutu B, Lucas M, Mtalib R, Obare P, Oloo F, Onoka C, Osoga J, Ohrt C, McKenzie FE, 2006. Systematic comparison of two methods to measure parasite density from malaria blood smears. Parasitol Res.
  46. Mayxay M, Pukrittayakamee S, Newton PN, White NJ, 2004. Mixed-species malaria infections in humans. Trends Parasitol 20: 233–240.[ISI][Medline]
  47. Lee MA, Tan CH, Aw LT, Tang CS, Singh M, Lee SH, Chia HP, Yap EP, 2002. Real-time fluorescence-based PCR for detection of malaria parasites. J Clin Microbiol 40: 4343–4345.[Abstract/Free Full Text]
  48. Perandin F, Manca N, Calderaro A, Piccolo G, Galati L, Ricci L, Medici MC, Arcangeletti MC, Snounou G, Dettori G, Chezzi C, 2004. Development of a real-time PCR assay for detection of Plasmodium falciparum, Plasmodium vivax, and Plasmodium ovale for routine clinical diagnosis. J Clin Microbiol 42: 1214–1219.[Abstract/Free Full Text]
  49. Rougemont M, Van Saanen M, Sahli R, Hinrikson HP, Bille J, Jaton K, 2004. Detection of four Plasmodium species in blood from humans by 18S rRNA gene subunit-based and species-specific real-time PCR assays. J Clin Microbiol 42: 5636–5643.[Abstract/Free Full Text]
  50. Mangold KA, Manson RU, Koay ES, Stephens L, Regner M, Thomson RB Jr, Peterson LR, Kaul KL, 2005. Real-time PCR for detection and identification of Plasmodium spp. J Clin Microbiol 43: 2435–2440.[Abstract/Free Full Text]
  51. Schneider P, Wolters L, Schoone G, Schallig H, Sillekens P, Hermsen R, Sauerwein R, 2005. Real-time nucleic acid sequence-based amplification is more convenient than real-time PCR for quantification of Plasmodium falciparum. J Clin Microbiol 43: 402–405.[Abstract/Free Full Text]
  52. Swan H, Sloan L, Muyombwe A, Chavalitshewinkoon-Petmitr P, Krudsood S, Leowattana W, Wilairatana P, Looareesuwan S, Rosenblatt J, 2005. Evaluation of a real-time polymerase chain reaction assay for the diagnosis of malaria in patients from Thailand. Am J Trop Med Hyg 73: 850–854.[Abstract/Free Full Text]
  53. Elsayed S, Plewes K, Church D, Chow B, Zhang K, 2006. Use of molecular beacon probes for real-time PCR detection of Plasmodium falciparum and other plasmodium species in peripheral blood specimens. J Clin Microbiol 44: 622–624.[Abstract/Free Full Text]
  54. Snounou G, Viriyakosol S, Jarra W, Thaithong S, Brown KN, 1993. Identification of the four human malaria parasite species in field samples by the polymerase chain reaction and detection of a high prevalence of mixed infections. Mol Biochem Parasitol 58: 283–292.[ISI][Medline]
  55. Postigo M, Mendoza-Leon A, Perez HA, 1998. Malaria diagnosis by the polymerase chain reaction: a field study in south-eastern Venezuela. Trans R Soc Trop Med Hyg 92: 509–511.[ISI][Medline]
  56. May J, Mockenhaupt FP, Ademowo OG, Falusi AG, Olumese PE, Bienzle U, Meyer CG, 1999. High rate of mixed and sub-patent malarial infections in southwest Nigeria. Am J Trop Med Hyg 61: 339–343.[Abstract]
  57. Singh B, Bobogare A, Cox-Singh J, Snounou G, Abdullah MS, Rahman HA, 1999. A genus- and species-specific nested polymerase chain reaction malaria detection assay for epidemiologic studies. Am J Trop Med Hyg 60: 687–692.[Abstract]
  58. Incardona S, Chy S, Chiv L, Nhem S, Sem R, Hewitt S, Doung S, Mercereau-Puijalon O, Fandeur T, 2005. Large sequence heterogeneity of the small subunit ribosomal RNA gene of Plasmodium ovale in cambodia. Am J Trop Med Hyg 72: 719–724.[Abstract/Free Full Text]
  59. Coleman RE, Maneechai N, Rachaphaew N, Kumpitak C, Miller RS, Soyseng V, Thimasarn K, Sattabongkot J, 2002. Comparison of field and expert laboratory microscopy for active surveillance for asymptomatic Plasmodium falciparum and Plasmodium vivax in western Thailand. Am J Trop Med Hyg 67: 141–144.[Abstract]
  60. Kain KC, Kyle DE, Wongsrichanalai C, Brown AE, Webster HK, Vanijanonta S, Looareesuwan S, 1994. Qualitative and semi-quantitative polymerase chain reaction to predict Plasmodium falciparum treatment failure. J Infect Dis 170: 1626–1630.[ISI][Medline]
  61. Jarra W, Snounou G, 1998. Only viable parasites are detectec by PCR following clearance of rodent malarial infections by drug treatment or immune responses. Infect Immun 66: 3783–3787.[Abstract/Free Full Text]
  62. Kawamoto F, Win TT, Mizuno S, Lin K, Kyaw O, Tantulart IS, Mason DP, Kimura M, Wongsrichanalai C, 2002. Unusual plasmodium malariae-like parasites in southeast Asia. J Parasitol 88: 350–357.[Medline]
  63. Snounou G, White NJ, 2004. The co-existence of Plasmodium: sidelights from falciparum and vivax malaria in Thailand. Trends Parasitol 20: 333–339.[ISI][Medline]
  64. Hii JL, Smith T, Vounatsou P, Alexander N, Mai A, Ibam E, Alpers MP, 2001. Area effects of bednet use in a malaria-endemic area in Papua New Guinea. Trans R Soc Trop Med Hyg 95: 7–13.[ISI][Medline]
  65. Smith T, Hii JL, Genton B, Muller I, Booth M, Gibson N, Narara A, Alpers MP, 2001. Associations of peak shifts in age–prevalence for human malarias with bednet coverage. Trans R Soc Trop Med Hyg 95: 1–6.[ISI][Medline]



This article has been cited by other articles:


Home page
 Am J Trop Med HygHome page
J. Marfurt, I. Mueller, A. Sie, P. Maku, M. Goroti, J. C. Reeder, H.-P. Beck, and B. Genton
Low Efficacy of Amodiaquine or Chloroquine Plus Sulfadoxine-Pyrimethamine against Plasmodium falciparum and P. vivax Malaria in Papua New Guinea
Am J Trop Med Hyg, November 1, 2007; 77(5): 947 - 954.
[Abstract] [Full Text] [PDF]

Home page
 Am J Trop Med HygHome page
P. MICHON, J. L. COLE-TOBIAN, E. DABOD, S. SCHOEPFLIN, J. IGU, M. SUSAPU, N. TARONGKA, P. A. ZIMMERMAN, J. C. REEDER, J. G. BEESON, et al.
THE RISK OF MALARIAL INFECTIONS AND DISEASE IN PAPUA NEW GUINEAN CHILDREN
Am J Trop Med Hyg, June 1, 2007; 76(6): 997 - 1008.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Microbiol.Home page
E. P. Carnevale, D. Kouri, J. T. DaRe, D. T. McNamara, I. Mueller, and P. A. Zimmerman
A Multiplex Ligase Detection Reaction-Fluorescent Microsphere Assay for Simultaneous Detection of Single Nucleotide Polymorphisms Associated with Plasmodium falciparum Drug Resistance
J. Clin. Microbiol., March 1, 2007; 45(3): 752 - 761.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Supplemental Figure and Table
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (6)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by KASEHAGEN, L. J.
Right arrow Articles by ZIMMERMAN, P. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by KASEHAGEN, L. J.
Right arrow Articles by ZIMMERMAN, P. A.
Related Collections
Right arrow